{
    "organizations": [],
    "uuid": "5cac2d627516d1b3d72aafe6b6c24332957ba829",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-intec-pharma-to-voluntarily-delist/brief-intec-pharma-to-voluntarily-delist-from-trading-on-the-tel-aviv-stock-exchange-idUSFWN1SM1FS",
    "ord_in_thread": 0,
    "title": "BRIEF-Intec Pharma To Voluntarily Delist From Trading On The Tel Aviv Stock Exchange",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 15 (Reuters) - Intec Pharma Ltd:\n* INTEC PHARMA SAYS BOARD DECIDED TO TAKE STEPS TO VOLUNTARILY DELIST CO’S ORDINARY SHARES FROM TRADING ON THE TEL AVIV STOCK EXCHANGE LTD - SEC FILING\n* FOLLOWING DELISTING IN ISRAEL, CO’S ORDINARY SHARES WILL CONTINUE TO TRADE ON THE NASDAQ CAPITAL MARKET IN THE UNITED STATES Source text :( bit.ly/2rERYRV ) Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles. ",
    "published": "2018-05-16T06:40:00.000+03:00",
    "crawled": "2018-05-16T19:21:51.013+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "intec",
        "pharma",
        "ltd",
        "intec",
        "pharma",
        "say",
        "board",
        "decided",
        "take",
        "step",
        "voluntarily",
        "delist",
        "co",
        "ordinary",
        "share",
        "trading",
        "tel",
        "aviv",
        "stock",
        "exchange",
        "ltd",
        "sec",
        "filing",
        "following",
        "delisting",
        "israel",
        "co",
        "ordinary",
        "share",
        "continue",
        "trade",
        "nasdaq",
        "capital",
        "market",
        "united",
        "state",
        "source",
        "text",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}